The reported daily fluid intake decreased for patients on dulaglutide from a median (IQR) of 4500 [3625, 5000] mL to 3000 [2500, 3875] mL, while it remained constant with placebo treatment, from 4000 [4000, 5000] mL to 4000 [3500, 5000] mL
What will happen to health insurance premiums
These medications work well for diabetes management and weight loss, but they come with risks beyond their well-known side effects
O., Fellowes, A
58 More results beyond those highlighted in the next section are available for exploration in the interactive R ShinyApp, including details on cohort attribution, PS distributions and fitted PS models, study diagnostics, HR estimates under alternative TAR definitions, and alternative diagnostic thresholds